62.82
price down icon3.13%   -2.03
after-market Dopo l'orario di chiusura: 62.82
loading
Precedente Chiudi:
$64.85
Aprire:
$65.24
Volume 24 ore:
656.73K
Relative Volume:
1.06
Capitalizzazione di mercato:
$1.34B
Reddito:
$56.54M
Utile/perdita netta:
$-30.70M
Rapporto P/E:
-161.08
EPS:
-0.39
Flusso di cassa netto:
$-31.05M
1 W Prestazione:
+11.88%
1M Prestazione:
+34.12%
6M Prestazione:
+232.21%
1 anno Prestazione:
+430.57%
Intervallo 1D:
Value
$62.00
$65.24
Intervallo di 1 settimana:
Value
$54.52
$66.94
Portata 52W:
Value
$10.14
$66.94

Cidara Therapeutics Inc Stock (CDTX) Company Profile

Name
Nome
Cidara Therapeutics Inc
Name
Telefono
858-752-6170
Name
Indirizzo
6310 NANCY RIDGE DRIVE, SAN DIEGO, CA
Name
Dipendente
73
Name
Cinguettio
@CidaraThera
Name
Prossima data di guadagno
2024-10-31
Name
Ultimi documenti SEC
Name
CDTX's Discussions on Twitter

Confronta CDTX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CDTX
Cidara Therapeutics Inc
62.82 1.36B 56.54M -30.70M -31.05M -0.39
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Cidara Therapeutics Inc Stock (CDTX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-06-18 Ripresa H.C. Wainwright Buy
2025-03-12 Iniziato Citizens JMP Mkt Outperform
2025-01-27 Ripresa Cantor Fitzgerald Overweight
2024-12-13 Iniziato RBC Capital Mkts Outperform
2024-11-08 Iniziato Guggenheim Buy
2024-08-14 Aggiornamento H.C. Wainwright Neutral → Buy
2021-12-03 Ripresa H.C. Wainwright Buy
2021-09-22 Aggiornamento WBB Securities Buy → Strong Buy
2021-03-04 Iniziato Aegis Capital Buy
2019-09-04 Aggiornamento Wedbush Neutral → Outperform
2018-07-26 Iniziato Citigroup Buy
2017-04-21 Iniziato Raymond James Strong Buy
2017-04-17 Reiterato H.C. Wainwright Buy
2017-04-12 Iniziato Ladenburg Thalmann Buy
2017-04-11 Ripresa Wedbush Outperform
2017-02-22 Reiterato H.C. Wainwright Buy
2017-02-22 Aggiornamento WBB Securities Sell → Hold
2016-12-21 Ripresa Leerink Partners Outperform
2016-12-19 Iniziato H.C. Wainwright Buy
2016-09-23 Downgrade WBB Securities Hold → Sell
2015-10-09 Aggiornamento WBB Securities Sell → Hold
2015-05-11 Iniziato Jefferies Buy
2015-05-11 Iniziato Leerink Partners Outperform
2015-05-11 Iniziato Needham Buy
2015-05-11 Iniziato Wedbush Outperform
2015-04-23 Iniziato WBB Securities Sell
Mostra tutto

Cidara Therapeutics Inc Borsa (CDTX) Ultime notizie

pulisher
Jul 24, 2025

What drives Cidara Therapeutics Inc. stock priceHigh-return market picks - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Will Cidara Therapeutics Inc. stock benefit from interest rate changesFree Investment Community - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 24, 2025

What analysts say about Cidara Therapeutics Inc. stockFree Consultation - Autocar Professional

Jul 24, 2025
pulisher
Jul 24, 2025

Cidara Therapeutics to Report Second Quarter 2025 Financial - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

Cidara Therapeutics Sets Q2 Earnings Date: Key Updates on DFC Immunotherapy Platform Expected - Stock Titan

Jul 24, 2025
pulisher
Jul 23, 2025

Is Cidara Therapeutics Inc. a good long term investmentMarket-beating returns - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Cidara more than doubles on phase 2 flu preventative data - MSN

Jul 22, 2025
pulisher
Jul 20, 2025

(CDTX) On The My Stocks Page - news.stocktradersdaily.com

Jul 20, 2025
pulisher
Jul 19, 2025

ATAI Impresses, CDTX Navigates With Confidence, MTSR Builds Momentum, COGT Keeps Scaling The Summit… - RTTNews

Jul 19, 2025
pulisher
Jul 18, 2025

Cidara Therapeutics Inc. Stock Analysis and ForecastFree Predictions - jammulinksnews.com

Jul 18, 2025
pulisher
Jul 18, 2025

Growth or Bubble? Unpacking CDTX Stock Surge - timothysykes.com

Jul 18, 2025
pulisher
Jul 18, 2025

Cidara Therapeutics stock hits 52-week high at 56.85 USD By Investing.com - Investing.com India

Jul 18, 2025
pulisher
Jul 18, 2025

Cidara Therapeutics stock hits 52-week high at 56.85 USD - Investing.com

Jul 18, 2025
pulisher
Jul 16, 2025

Cidara Therapeutics, Inc. (NASDAQ:CDTX) Receives Average Rating of “Buy” from Brokerages - Defense World

Jul 16, 2025
pulisher
Jul 15, 2025

What makes Cidara Therapeutics Inc. stock price move sharplyWatchlist Winner Update - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Cidara Therapeutics Inc. stock attracts strong analyst attentionConsistent Growth Alert - newser.com

Jul 15, 2025
pulisher
Jul 07, 2025

Finance Watch: A Mini-Surge In Follow-On Offerings Follows Positive Updates - insights.citeline.com

Jul 07, 2025
pulisher
Jul 07, 2025

Segal Trials Contributes to Breakthrough Flu Prevention Study Led by Cidara Therapeutics - Business Wire

Jul 07, 2025
pulisher
Jul 06, 2025

Cidara Therapeutics announces inclusion in the Russell 2000 and 3000 indexes - MSN

Jul 06, 2025
pulisher
Jul 02, 2025

Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times

Jul 02, 2025
pulisher
Jul 01, 2025

Cidara Therapeutics shares fall 5.99% after-hours following inducement grants announcement. - AInvest

Jul 01, 2025
pulisher
Jun 30, 2025

Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains - TradingView

Jun 30, 2025
pulisher
Jun 30, 2025

hVIVO reports positive results from Cidara’s Phase 2b influenza study By Investing.com - Investing.com Canada

Jun 30, 2025
pulisher
Jun 29, 2025

(CDTX) Technical Pivots with Risk Controls - news.stocktradersdaily.com

Jun 29, 2025
pulisher
Jun 27, 2025

Phathom Pharmaceuticals shares rise 1.47% premarket after Cidara Therapeutics closes $402.5 million stock offering. - AInvest

Jun 27, 2025
pulisher
Jun 26, 2025

Cidara Therapeutics prices upsized $350 milion stock offering at $44 - MSN

Jun 26, 2025
pulisher
Jun 25, 2025

Cidara Therapeutics Advances CD388 To Phase 3, Reiterated Buy (NASDAQ:CDTX) - Seeking Alpha

Jun 25, 2025
pulisher
Jun 24, 2025

Cidara Therapeutics (CDTX) Price Target Raised by RBC Capital | CDTX Stock News - GuruFocus

Jun 24, 2025
pulisher
Jun 24, 2025

Cidara Therapeutics announces $250M public stock offering - MSN

Jun 24, 2025
pulisher
Jun 24, 2025

Cidara stock surges as H.C. Wainwright raises price target on trial data By Investing.com - Investing.com South Africa

Jun 24, 2025
pulisher
Jun 24, 2025

Cidara Therapeutics suspends ATM prospectus for common stock sales By Investing.com - Investing.com Nigeria

Jun 24, 2025
pulisher
Jun 24, 2025

Cidara Therapeutics Stock Jumps After-Hours As Strong Flu Trial Data Outweighs $250M Share Offering - MSN

Jun 24, 2025
pulisher
Jun 23, 2025

Form 424B5 Cidara Therapeutics, - StreetInsider

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics (CDTX) to Launch $250M Public Offering | CDT - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics plans $250 million common stock offering By Investing.com - Investing.com Canada

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics Announces Plans for $250 Million Underwritten Public Offering of Common Stock - Quiver Quantitative

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics (CDTX) Price Target Boosted Following Positi - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics (CDTX) Receives Strong Buy Rating from WBB Securities | CDTX Stock News - GuruFocus

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics Stock Rises as Strategic Partnerships Strengthen Position - timothysykes.com

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza - The Manila Times

Jun 23, 2025
pulisher
Jun 23, 2025

Cidara Therapeutics Announces Positive Topline Results From Its Phase 2B Navigate Trial - TradingView

Jun 23, 2025
pulisher
Jun 23, 2025

Crude Oil Falls 1%; US Services PMI Declines In June - Benzinga

Jun 23, 2025
pulisher
Jun 20, 2025

Cidara Therapeutics Approves Key Amendments at Annual Meeting - TipRanks

Jun 20, 2025
pulisher
Jun 19, 2025

(CDTX) Proactive Strategies - news.stocktradersdaily.com

Jun 19, 2025
pulisher
Jun 18, 2025

Cidara Therapeutics (CDTX) Receives Buy Rating from HC Wainwrigh - GuruFocus

Jun 18, 2025
pulisher
Jun 18, 2025

H.C. Wainwright assumes coverage on Cidara stock with buy rating By Investing.com - Investing.com UK

Jun 18, 2025
pulisher
Jun 18, 2025

H.C. Wainwright Initiates Coverage on Cidara Therapeutics (CDTX) with Strong Outlook | CDTX Stock News - GuruFocus

Jun 18, 2025
pulisher
Jun 11, 2025

Cidara Therapeutics (NASDAQ:CDTX) Given Overweight Rating at Cantor Fitzgerald - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

Cidara Therapeutics (CDTX) Reiterates Overweight Rating by Canto - GuruFocus

Jun 10, 2025
pulisher
Jun 06, 2025

(CDTX) Investment Analysis - news.stocktradersdaily.com

Jun 06, 2025
pulisher
Jun 06, 2025

Millennium Management LLC Raises Stock Holdings in Cidara Therapeutics, Inc. (NASDAQ:CDTX) - Defense World

Jun 06, 2025

Cidara Therapeutics Inc Azioni (CDTX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):